Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 300-344-4 | CAS number: 93925-42-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February to march 2005
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- see free text
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- see free text
- Qualifier:
- according to guideline
- Guideline:
- other: OPPTS 870.1000
- Deviations:
- yes
- Remarks:
- see free text
- Principles of method if other than guideline:
- There was the following deviation to the project protocol.
Concerning:
Administration, p 10 of the project protocol
Before:
Volume of administration: The test item will be administered according to bodyweight at a volume of 10mL/kg bw if technically possible.
New:
Volume of administration: The test item was administered according to bodyweight at a volume of 5 mL/kg bw.
Reason:
5 mL were used for administration as the test item was already soluble in 5mL. Due to animal welfare reasons, 5 mL were preferred as this smaller amount was less stress for the animals. - GLP compliance:
- yes
- Remarks:
- Bayrisches Landesamt für Arbeitsschutz, Arbeitsmedizin und Sicherheitstechnik, München, Germany
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dibutylstannane
- EC Number:
- 300-344-4
- EC Name:
- Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dibutylstannane
- Cas Number:
- 93925-42-9
- Molecular formula:
- C12H24O4Sn.C8H20O4Si
- IUPAC Name:
- Acetic acid, 1,1'-(dibutylstannylene) ester, reaction products with silicic acid (H4SiO4) tetra-Et ester
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- cotton seed oil
- Doses:
- 300, 2000 mg/kg bw
- No. of animals per sex per dose:
- 3+3
- Control animals:
- no
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 000 mg/kg bw
- Based on:
- test mat.
Any other information on results incl. tables
Results:
Sex |
Dose (mg/kg) |
Number of animals |
Number of deaths |
Female |
300 |
3 |
1 |
Female |
300 |
3 |
0 |
Female |
2000 |
3 |
2 |
Female |
2000 |
3 |
2 |
Signs of toxicity related to dose level used, time of onset and duration:
Animal No. 1 of step 3 (2000 mg/kg bw):
4 days post-dose slight reduced spontaneous activity, apathy, piloerection, weight reduction (140 g)
5 days post-dose slight reduced spontaneous activity, apathy, piloerection, weight reduction (139 g), abdominal respiration
6 days post-dose moderate reduced spontaneous activity, apathy, piloerection, weight reduction (134 g), abdominal respiration
7 days post-dose moderate reduced spontaneous activity, apathy, piloerection, weight reduction (128 g)
8 days post-dose death. (123 g)
Animal No. 2 of step 3 (2000 mg/kg bw):
4 days post-dose slight reduced spontaneous activity, apathy, piloerection, weight reduction (147 g)
5 days post-dose slight reduced spontaneous activity, half eyelid closure, apathy, piloerection, weight reduction (146 g), abdominal respiration
6 days post-dose moderate reduced spontaneous activity, half eyelid closure, apathy, piloerection, weight reduction (137 g), abdominal respiration
7 days post-dose death.
Animal No. 1 of step 4 (2000 mg/kg bw):
26.5 hours post-dose slight reduced spontaneous activity, apathy, labored respiratory, cyanosis at extremities and mucosa, piloerection27.5 hours post-dose moderate reduced spontaneous activity, abdominal position, apathy, labored respiratory, cyanosis at extremities and mucosa, piloerection
28 hours post-dose death
Animal No. 2 of step 4 (2000 mg/kg bw):
4 days post-dose slight reduced spontaneous activity, weight reduction (156g), piloerection
5 days post-dose slight reduced spontaneous activity, weight reduction (152g), piloerection, abdominal respiration
6 days post-dose slight reduced spontaneous activity, weight reduction (141g), piloerection
7 days post-dose slight reduced spontaneous activity, weight reduction (132g), piloerection
8 days post-dose slight reduced spontaneous activity, weight reduction (123g), piloerection
9 days post-dose weight reduction (130 g), piloerection
10 days post-dose (135 g), piloerection
11 days post-dose (143 g), piloerection
12 days post-dose (150 g), slight piloerection
13 days post-dose no signs of toxicity recorded
Animal No. 3 of step 4 (2000 mg/kg bw):
4 days post-dose slight reduced spontaneous activity, weight reduction (135g), piloerection
5 days post-dose slight reduced spontaneous activity, weight reduction (127g), piloerection, abdominal respiration
6 days post-dose slight reduced spontaneous activity, apathy, weight reduction (123 g), piloerection
7 days post-dose death, (118 g, piloerection)
No other treatment related clinical effects were observed in any animals of any steps.
Effect on organs (related to dose level):
Animal No. 3 of step 1 (300 mg/kg bw):
The animal died within the sixth night post-dose. The next morning necropsy was not possible, as due to cannibalism only residual parts without any organs of this animal were found.
Animal No. 1 of step 3 (2000 mg/kg bw):
Lateral recumbency, rough coat.
Animal No. 1 of step 4 (2000 mg/kg bw):
Abdominal position, opened mouth after death, liver notable dark colored (maybe congestion); right lung superior bloodinfiltrated.
Animal No. 3 of step 4 (2000 mg/kg bw):
Abdominal position, rough coat.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- According to GHS (Globally Harmonized Classification System) the test item Wacker Katalysator 41 was classified into Category 4 (LD50 cut-off: 1000 mg/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.